Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Bocci

Showing results (11-20 of 154) with videos related to

Pageof 16
Sort By:
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors: A Scoping ReviewCostanza Tacchi, Irma Convertino, Guido Bocci
Critical Reviews in Oncology/Hematology|June 7, 2011
Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?Nicolas Penel, Antoine Adenis, Guido Bocci
Journal of Anatomy|June 15, 2017
Scholars and scientists in the history of the lymphatic systemGianfranco Natale, Guido Bocci, Domenico Ribatti
Angiogenesis|February 8, 2013
The pharmacological bases of the antiangiogenic activity of paclitaxelGuido Bocci, Antonello Di Paolo, Romano Danesi
Cancer Letters|April 18, 2024
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedulesMarta Banchi, Maria Christina Cox, Guido Bocci
Cancer Research|December 4, 2002
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugsGuido Bocci, K C Nicolaou, Robert S Kerbel
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Journal of Clinical Medicine|November 11, 2022
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical StudiesMarta Banchi, Elisabetta Fini, Stefania Crucitta, et al.
Pharmacological Research|November 17, 2021
Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical dataFederico Cucchiara, Sara Ferraro, Giacomo Luci, et al.
Pharmacological Research|February 1, 2002
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cellsGuido Bocci, Romano Danesi, Anna Fioravanti, et al.
Pageof 16

Showing results (11-20 of 154) with videos related to

Sort By:
Pageof 16
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Immune-Related Adverse Events Associated with Immune Checkpoint Inhibitors: A Scoping ReviewCostanza Tacchi, Irma Convertino, Guido Bocci
Critical Reviews in Oncology/Hematology|June 7, 2011
Cyclophosphamide-based metronomic chemotherapy: after 10 years of experience, where do we stand and where are we going?Nicolas Penel, Antoine Adenis, Guido Bocci
Journal of Anatomy|June 15, 2017
Scholars and scientists in the history of the lymphatic systemGianfranco Natale, Guido Bocci, Domenico Ribatti
Angiogenesis|February 8, 2013
The pharmacological bases of the antiangiogenic activity of paclitaxelGuido Bocci, Antonello Di Paolo, Romano Danesi
Cancer Letters|April 18, 2024
Metronomic chemotherapy in hematology: Lessons from preclinical and clinical studies to build a solid rationale for future schedulesMarta Banchi, Maria Christina Cox, Guido Bocci
Cancer Research|December 4, 2002
Protracted low-dose effects on human endothelial cell proliferation and survival in vitro reveal a selective antiangiogenic window for various chemotherapeutic drugsGuido Bocci, K C Nicolaou, Robert S Kerbel
Medical Oncology (Northwood, London, England)|February 29, 2020
Preclinical and clinical combination therapies in the treatment of anaplastic thyroid cancerDaniela Gentile, Paola Orlandi, Marta Banchi, et al.
Journal of Clinical Medicine|November 11, 2022
Metronomic Chemotherapy in Pediatric Oncology: From Preclinical Evidence to Clinical StudiesMarta Banchi, Elisabetta Fini, Stefania Crucitta, et al.
Pharmacological Research|November 17, 2021
Relevant pharmacological interactions between alkylating agents and antiepileptic drugs: Preclinical and clinical dataFederico Cucchiara, Sara Ferraro, Giacomo Luci, et al.
Pharmacological Research|February 1, 2002
The effect of osteogenic growth peptide (OGP) on proliferation and adhesion of HEMC-1 human endothelial cellsGuido Bocci, Romano Danesi, Anna Fioravanti, et al.
Pageof 16